Although there is a large body of evidence on the involvement of PLC β isozymes in cardiac hypertrophy, the contribution of other myocardial PLC isozymes to the cardiomyocyte hypertrophic response is less defined, but information is now emerging. The gene discussed is HSPG2; the disease is cardiac hypertrophy.